3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
3
Melanoma
2
Urinary Bladder Neoplasms
1
Spondylitis, Ankylosing
1
Skin Carcinoma
1
Signs and Symptoms
1
Rectal Neoplasms
1
Psoriasis
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Motor Activity
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lymphedema
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Interventions
Fluorouracil
10
Oxaliplatin
8
Capecitabine
8
pembrolizumab
6
Specimen Handling
6
Nivolumab
6
Leucovorin
6
trastuzumab deruxtecan
5
Magnetic Resonance Spectroscopy
5
Paclitaxel
4
Cisplatin
4
Biopsy
4
fludarabine
3
aldesleukin
3
Trastuzumab
3
Cyclophosphamide
3
zolbetuximab
2
fludarabine phosphate
2
Ramucirumab
2
Folfox protocol
2
Docetaxel
2
zimberelimab
1
zanidatamab
1
ulixertinib
1
tucatinib
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
toripalimab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Methods
×
30 days
×
Clear all
No trials found.